Drug Maker Mylan Standing Firm on EpiPen Price Hike

CEO Heather Bresch said the skyrocketing price had to do with issues within the health care system.
1:36 | 08/25/16

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for Drug Maker Mylan Standing Firm on EpiPen Price Hike

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"1:36","description":"CEO Heather Bresch said the skyrocketing price had to do with issues within the health care system.","mediaType":"default","section":"ABCNews/WNT","id":"41660003","title":"Drug Maker Mylan Standing Firm on EpiPen Price Hike","url":"/WNT/video/drug-maker-mylan-standing-firm-epipen-price-hike-41660003"}